Opioids Drugs Market- Global Industry Trends, Size, Share and Analytics 2019-2027

GLOBAL OPIOIDS DRUG MARKET FORECAST 2019-2027

• The global opioids drugs market is anticipated to grow at a CAGR of 2.52% between 2019 and 2027. • Opioids are narcotic drugs and mostly directed for pain management. Increasing case of road accidents & surgical procedures are the main drivers that are propagating the global market growth for opioids drugs.

• The opioid drugs are commonly used for alleviating the postoperative pains caused by surgical procedures.

• Opioid drugs are approved by FDA in the United States with ADF labeling and are currently marketed in North America.

• The market is segmented by products and applications, out of which, the former’s oxycodone sub-segment is estimated to hold the highest market share in 2018.

• Growing demand for palliative care that aims to improve the quality of life for the patient suffering from terminal illness by implementing the use of opioid drugs is further driving the said market’s growth.

• The growing opioid addiction crisis is leading to submission of lawsuits against pharmaceuticals companies who are manufacturing the opioid drugs.

“The global opioids drugs market is anticipated to grow at a CAGR of 2.52% between 2019 and 2027.�

The North America opioids drug market is expected to contribute the majority of share X% by 2027. Also, the market is growing steadily at 2.29% CAGR during the forecast tenure of 2019-2027.

Europe accounts for a significant share of the global market of opioid drugs, accounting for approximately X % in 2018 and is apprehended to proliferate at a CAGR of 2.49% to reach $XX billion in revenue by 2027.

The Asia Pacific opioids drug market growth has been quantified to be 3.06% during the forecast period 2019-2027.

Acura Pharmaceuticals, Inc., Allergan PLC, BioDelivery Sciences International, Inc., Cipher Pharmaceuticals, Inc., Collegium Pharmaceutical, Inc., Daiichi Sankyo, Inc., Egalet Corp., Hikma Pharmaceuticals PLC, Indivior, Inc., Insys Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Lannett Co. Inc., Lupin Ltd., Mylan NV, Pfizer, Inc., Purdue Pharma LP, Sanofi-Aventis S.A., Sun Pharmaceutical Industries Limited (Sun Pharma) and Teva Pharmaceutical Industries Ltd. are some of the key market players who are dominating the global opioids market.